The death toll at the Telangana factory blast at Sigachi Industries has reached 44 making it one of the most tragic industrial calamities in the state. The incident occurred on June 30, at the company's manufacturing plant at Pashamylaram in the...
NITI Aayog requested across-the-board quality makeover of India's pharma industry, while top industry bodies rang alarm bells on systemic issues that are stifling compliance with international standards.
Aster DM Healthcare has established its objective to become India’s largest hospital chain, implementing an aggressive expansion plan in Tier-2 cities like Indore, Raipur, Aurangabad and Bhubaneswar...
In a remarkable move, Nectar Lifesciences announced the sale of its core active pharmaceutical ingredients (API), formulations and menthol business to Ceph Lifesciences Pvt Ltd, a total consideration of Rs 1,290 crore. The transaction includes a...
WIKA Instruments India, the world's leading precision measurement solution provider, has introduced its newest strategic movement titled 'Re-Inventing Hygiene' to revolutionize the standard of hygiene in the pharmaceutical sector.
Building on recent efforts to enhance healthcare and pharmaceutical cooperation, India and Uzbekistan are eager to explore new areas of collaboration following a virtual session.
The Pharmaceutical Automation and Digitalisation Congress (AUTOMA+) 2025 welcomes delegates to be a part of its 5th anniversary in Vösendorf, Austria on 24-25 November. This edition focuses on AI-powered pharma, robotics and smart digital solutions.
.jpeg "DCC Approves Amendments to Stem Cell & Gene Therapy Licensing Rules")
Drugs Consultative Committee (DCC) has sanctioned the modification of the Drugs Rules, 1945, so that products derived from stem cells and gene therapy products can be encompassed in securing a manufacturing license.
Emcure Pharmaceuticals has incorporated a new wholly-owned subsidiary, Emcure Wellness Private Limited, indicating a strategic direction towards diversifying within India's growing healthcare and wellness sector. The new subsidiary was formed on...
.jpeg "J&J Seeks EMA Nod to Expand Akeega Use in Prostate Cancer Cases")
Janssen-Cilag International NV, which is a Johnson & Johnson subsidiary, submitted an extension of indication application to the European Medicines Agency (EMA) for the approval of AKEEGA
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")